5YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
Albendazole | 阿苯达唑 | 54965-21-8 |
Camicinal;GSK962040 | GSK 962040 | 923565-21-3 |
GSK-J2 | N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 | 1394854-52-4 |
GSK-3 inhibitor 1 | 3-(9-氟-1,2,3,4-四氢吡咯并[3,2,1-JK][1,4]苯并二氮杂卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮单盐酸盐 | 603272-51-1 |
Fiboflapon;AM-803;GSK2190915 | FIBOFLAPON | 936350-00-4 |
Golotimod | H-D-GLU(TRP-OH)-OH | 229305-39-9 |
Guanfu base H;Atisinium chloride | GUANFU BASE H | 4758-99-0 |
GlyRS-IN-1 | 112921-11-6 | 112921-11-6 |
GPR120 Agonist 1 | GPR120 agonist 4x | 1628448-77-0 |
GSK1521498 free base (hydrochloride) | GSK1521498 FREE BASE (HYDROCHLORIDE) | 1007578-24-6 |
GSK2593074A | GSK2593074A | 1337531-06-2 |
GSK598809 | GSK598809 | 863680-45-9 |
GSK-3β inhibitor 1 | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- | 187325-53-7 |
Lenacapavir | HIV-1衣壳抑制剂GS-6207 | 2189684-44-2 |
GSK2973980A | GSK2973980A | 2219321-25-0 |
Guaiapate | 愈创哌特 | 852-42-6 |
GPR120 modulator 1 | 2-[4-[[4-(2-氯苯基)-2-噻唑基]甲氧基]-2-甲基苯氧基]乙酸 | 1050506-75-6 |
GPR40 Activator 2 | 化合物 T11457 | 1312787-30-6 |
Guanfu base I;Acorine | 关附壬素 | 110225-59-7 |
GSK2239633A | 1240516-71-5 | 1240516-71-5 |
Molibresib besylate;GSK 525762C;I-BET 762 besylate | MOLIBRESIB BESYLATE | 1895049-20-3 |
GPR40/FFAR1 modulator 1 | GPR40/FFAR1 modulator 1 | 874755-26-7 |
Roxithromycin | 罗红霉素 | 80214-83-1 |
Gum arabic;Arabic gum | 阿拉伯胶 | 9000-01-5 |
GSTO1-IN-1 | 568544-03-6 | 568544-03-6 |
GYKI 52466 dihydrochloride | GYKI 52466 dihydrochloride | 2319722-40-0 |
H-89 | N-[2-[P-溴苯丙烯盐基氨基]乙基]-5-异喹啉磺酰胺 | 127243-85-0 |
GPR120 modulator 2 | 4-[[4-(2-氯苯基)-2-噻唑基]甲氧基]-2-甲基苯丙酸 | 1050506-87-0 |
GSK256066 Trifluoroacetate;GSK 256066 Trifluoroacetate;GSK256066 (2,2,2-trifluoroacetic acid) | GSK256066 三氟乙酸盐 | 1415560-64-3 |
GSK 525768A | GSK 525768A | 1260530-25-3 |
GW806742X | CS-2659 | 579515-63-2 |
GSK2850163 | 2121989-91-9 | 2121989-91-9 |
GNE-8505 | GNE-8505 | 1620573-48-9 |
GW 766994;GW 994 | GW 766994 | 408303-43-5 |
GSK205 | GSK205 | 1263068-83-2 |
GW274150 | 化合物 T11518L | 210354-22-6 |
GV-196771A | 166974-23-8 | 166974-23-8 |
GPI-1046 | 1-(1,2-二氧代-3,3-二甲基戊基)-L脯氨酸-(3-吡啶基)-丙酯 | 186452-09-5 |
Gosogliptin;PF-00734200;PF-734200 | (3,3-二氟吡咯烷-1-基)[(2S,4S)-4-[4-(嘧啶-2-基)哌嗪-1-基]吡咯烷-2-基]甲酮 | 869490-23-3 |
Camicinal hydrochloride;GSK962040 hydrochloride | 923565-22-4 | 923565-22-4 |
GNF179 (Metabolite);GNF179 Metabolite | GNF179代谢物 | 1310455-86-7 |
Fiboflapon sodium;GSK2190915 sodium salt;AM-803 sodium | 化合物 T11487L | 1196070-26-4 |
GNF-6231 | GNF6231 | 1243245-18-2 |
GSK2245035 | GSK2245035 | 1207629-49-9 |
GSK-843 | GSK-843 | 1601496-05-2 |
GNE 220 | 1199590-75-4 | 1199590-75-4 |
Menbutone | 孟布酮 | 3562-99-0 |
GNF362 | GNF362 | 1003019-41-7 |
Lidocaine hydrochloride | 盐酸利多卡因 | 73-78-9 |
Guanoxabenz;Hydroxyguanabenz | 胍诺沙苄 | 24047-25-4 |
GPR40 Activator 1 | 1309435-60-6 | 1309435-60-6 |
GV-58 | (2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇 | 1402821-41-3 |
GRL0617 | 5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide | 1093070-16-6 |
GNA002 | GNA002 | 1385035-79-9 |
GSK4028 | 2079886-19-2 | 2079886-19-2 |
Lidocaine Hydrochloride hydrate | 盐酸利多卡因 | 6108-05-0 |
GSK1521498 | GSK1521498 | 1426543-84-1 |
GSK656 | 化合物 T11497 | 2131798-13-3 |
GPR84 antagonist 8 | GPR84 ANTAGONIST 8 | 1445846-30-9 |
GSK3368715;EPZ019997 | GSK3368715 | 1629013-22-4 |
GNF4877 | GNF4877 | 2041073-22-5 |
GSK3368715 dihydrochloride | GSK3368715 DIHYDROCHLORIDE | 1628925-77-8 |
GlyT1 Inhibitor 1 | GlyT1 Inhibitor 1 | 1820934-93-7 |
GSK-3β inhibitor 2 | GSK-3 β inhibitor 2 | 1702428-31-6 |
GW274150 phosphate | GW274150 PHOSPHATE | 438542-15-5 |
GPR4 antagonist 1 | GPR4 antagonist 1 | 1197879-16-5 |
Nifedipine;Procardia XL;Procardia;BAY-a-1040;Adalat | 硝苯地平 | 21829-25-4 |
GSK-5498A | 2,6-二氟-N-[1-[[2-氟-6-(三氟甲基)苯基]甲基]-1H-吡唑-3-基]苯甲酰胺 | 1253186-49-0 |
GSK1059865 | 1191044-58-2 | 1191044-58-2 |
GW768505A free base | GW768505A | 501693-25-0 |
Epelsiban;GSK 557296 | EPELSIBAN | 872599-83-2 |
GSK682753A | 1334294-76-6 | 1334294-76-6 |
GSK2945 | N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine | 1438071-12-5 |
GSK3532795;BMS-955176 | BMS-955176 | 1392312-45-6 |
GSK2807 Trifluoroacetate | GSK2807 Trifluoroacetate | 2245255-66-5 |
GNE-0439 | GNE0439 | 1241902-40-8 |
Glyoxalase I inhibitor | L-GAMMA-谷氨酰基-S-[[(4-溴苯基)羟基氨基]羰基]-L-半胱氨酰甘氨酸二乙酯单盐酸盐 | 221174-33-0 |
Guanosine-5'-triphosphate disodium salt | 鸟苷-5'-三磷酸二钠盐 | 56001-37-7 |
GSK1521498 free base | 1007573-18-3 | 1007573-18-3 |
NE 52-QQ57 | 2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole | 1401728-56-0 |
Chlorhexidine dihydrochloride;Chlorhexidine 2HCl;NSC-185;Chlorhexidine hydrochloride | 盐酸氯己定 | 3697-42-5 |
Fenofibrate | 非诺贝特 | 49562-28-9 |
GSK3004774 | GSK3004774 | 2138814-32-9 |
GSK 366 | GSK366) | 1953157-39-5 |
GZD856 | GZD856 | 1257628-64-0 |
GPR40 agonist 1 | GPR40 AGONIST 1 | 1853982-41-8 |
GSK-3484862 | GSK-3484862 | 2170136-65-7 |
Guancydine;Guancidine | 胍西定 | 1113-10-6 |
Gusperimus trihydrochloride;BMS181173;NKT-01;Spanidin | 盐酸胍立莫司 | 85468-01-5 |
Diminazene Aceturate | 4,4’-二脒基重氮氨基苯二乙尿酸 | 908-54-3 |
GR 103691 | GR 103691 | 162408-66-4 |
GSK2983559 free acid | 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate | 1579965-12-0 |
GSK 4027 | 化合物 T11495L | 2079896-25-4 |
GSTO-IN-2 | 1202710-57-3 | 1202710-57-3 |
GSK726701A | GSK726701A | 945721-87-9 |
GSK840;GSK'840 | GSK840 | 2361146-30-5 |
GPR35 agonist 1 | GPR35 agonist 1 | 2079880-92-3 |
GNE-616 | GNE-616 | 2349371-81-7 |
GOAT-IN-1 | GOAT-IN-1 | 1452473-54-9 |
GSK-2793660 | 2H-Pyran-4-carboxamide, 4-amino-N-[(1S,2E)-4-(2,3-dihydro-1H-indol-1-yl)-1-ethyl-4-oxo-2-buten-1-yl]tetrahydro- | 1613458-70-0 |
联系方式
电话:+1-781-999-5354
邮箱:marketing@targetmol.com
网址: https://www.targetmol.com/
产品总数: 32038
地址:36 Washington Street, Wellesley Hills, MA 02481
CB指数:58
国籍:美国